Prof. Porter Awarded a RO1
Dr. Porter was awarded a R01 from the NIH to develop perfluorocarbon nanoemulsions for the enhancement of MR-guided ultrasound ablation of kidney cancer.
Dr. Porter was awarded a R01 from the NIH to develop perfluorocarbon nanoemulsions for the enhancement of MR-guided ultrasound ablation of kidney cancer.